ICD-10-CM Billable Code

C83.0

Small cell B-cell lymphoma

Clinical Classification Guidelines

Inclusion Terms

  • Lymphoplasmacytic lymphoma
  • Nodal marginal zone lymphoma
  • Non-leukemic variant of B-CLL
  • Splenic marginal zone lymphoma

Excludes Type 1

  • chronic lymphocytic leukemia (C91.1)
  • mature T/NK-cell lymphomas (C84.-)
  • Waldenström macroglobulinemia (C88.00)

Medical Intelligence & Overview

Small cell B-cell lymphoma, classified under ICD-10 code C83.0, is a type of non-Hodgkin lymphoma that originates from B-lymphocytes, a kind of white blood cell. This condition involves the abnormal growth of small, mature-appearing B-cells within lymph nodes and other tissues. It can manifest in various forms, including lymphoplasmacytic lymphoma, nodal marginal zone lymphoma, and splenic marginal zone lymphoma, which differ based on their location and cellular characteristics. Although it shares similarities with other B-cell lymphomas, small cell B-cell lymphoma is notable for its specific cell size and behavior. Understanding its features can help in better awareness and management of this condition.

Causes & Symptoms

Clinical Causes: Genetic mutations affecting B-lymphocytes Chronic immune stimulation or infections Environmental exposures such as chemicals or pesticides Age-related changes in immune system function

Key Symptoms: Painless swelling of lymph nodes, typically in the neck, armpits, or groin Persistent fatigue or weakness Unexplained weight loss Fever and night sweats Abdominal discomfort or swelling if the spleen is involved Frequent infections due to immune system impairment

Diagnostic & Treatment

Diagnosis Path: Diagnosis of small cell B-cell lymphoma involves a combination of clinical evaluation, imaging studies, blood tests, and tissue biopsies. Key steps include: - Physical examination to detect swollen lymph nodes or organ enlargement - Imaging methods such as CT scans, PET scans, or MRI to assess the spread - Blood tests to evaluate blood cell counts and function - Biopsy of affected lymph nodes or tissues for microscopic examination and immunophenotyping, which identifies specific cell markers characteristic of this lymphoma - Bone marrow examination in cases where marrow involvement is suspected These procedures help determine the specific subtype and stage of the disease, guiding treatment options.

Treatment Protocols: Treatment strategies for small cell B-cell lymphoma depend on factors like disease stage, subtype, patient age, and overall health. Common approaches include: - Chemotherapy: Often the mainstay, using drugs targeting cancerous B-cells - Immunotherapy: Employs monoclonal antibodies to attack lymphoma cells - Targeted therapy: Drugs designed to interfere with specific molecular pathways involved in the lymphoma - Radiation therapy: Used in localized disease or specific areas - Stem cell transplant: Considered in aggressive or relapsed cases Supportive care may also be necessary to manage symptoms and maintain quality of life. Treatment plans are tailored to each patient’s unique situation, often involving a multidisciplinary team.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C83.0 a billable ICD-10 code?
Yes, C83.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C83.0?
Clinical documentation must specify the nature of Small cell B-cell lymphoma and any associated comorbidities for accurate reporting.

Cite this Clinical Reference